Obstetrics incl blue book epidural and nitrous Flashcards
Define PPH
Excessive bleeding in the first 24hrs post birth. Based on blood volume & changes in haemodynamic state (as blood loss often underestimated). VD >=500mL, CS >=1000mL, severe is >=1000mL, very severe >=2.5L
What’s class 1 haemorrhagic shock?
blood vol loss up to 15% (up to 750mL), pulse rate <100, BP normal, pulse pressure normal or increased, RR 14-20/min, urine output >30mL/hr, slightly anxious
what’s class 2 haemorrhagic shock?
blood loss 15-30% (750-1500mL), pulse rate 100-120bpm, BP normal, pulse pressure decreased, RR 20-30, urine output 20-30mL/min, mildly anxious
what’s class 3 haemorrhagic shock?
blood loss 30-40% (1.5-2L), pulse 120-140bpm, BP decreased, pp decreased, RR 30-45/min, UO 5-15mL/min, anxious/confused
what’s class 4 haemorrhagic shock?
blood loss >40% (>2L), pulse rate >140bpm, bp decreased, pp decreased, RR >35/min, UO negligible, CNS= confused/lethargic
What pt characteristics may cause them to show signs of shock after minimal blood vol loss?
small stature, anaemia, gestational HTN, proteinuria, dehydration
What lab test assists with retrospective Dx PPH?
decreased pp Hct by 10%
What are our circulation priorities with PPH?
reliable access- 2x large-bore IVs, one for WARMED fluid/blood products & one for drugs.
avoid dilutional coagulopathy- give rbc in preference to crystalloid but limit crystalloid to 2L
Consider running ROTEM/TEG to guide product replacement
Vasopressors to titrate MAP >65mmHg
urine output target >=30mL/hr
What’s the main cause of PPH?
Tone (uterine atony)- 70%
What’s the pharmacologic management for uterine atony?
ensure 3rd stage oxytocin given
1st line uterotonics:
-Further oxytocin 5IU over 1-2 mins
Can give further oxytocin after 5 mins (to max 10IU total)
Infusion: 30IU in 500mL CSL, at 166.6mL/hr (10IU/hr); oxytocin has T1/2B of 1-7mins, need infusion for sustained levels. Incr amplitude & freq of uterine contractions but not basal tone.
-ergometrine 250microg IM or 250-500microg (25microg at a time IV (diluted to 5mL)) over 1-2 mins UNLESS CONTRAINDICATED. Can repeat dose after 5 mins, max total dose 1mg- consider concomitant anti-emetic
-misoprostol 800-1000microg PR or 800microg S/L, once only. should consider if blood loss after 3rd stage oxytocic is >=350mL
2nd line uterotonics:
-carboprost, UNLESS CONTRAINDICATED, 250microg IM (can repeat 15-minutely up to a max 2mg or 8 doses) OR 500microg intramyometrial (manufacturer doesn’t recommend). Avail under special access scheme. MUST have cardiac monitoring & O2 therapy prior to administration.
Why give oxytocin slowly?
may be associated with hypotension, flushing, tachycardia, arrhythmia & myocardial ischemia. infusion may be safer if CV disorders. dose-dependent N&V.
What are the contraindications to ergometrine?
retained placenta, pre-eclampsia, severe/persistent sepsis, renal/hepatic/CV disease, PET.
How is misoprostol given, when should it be considered & what are some issues with it?
800-1000microg PR or 800microg sublingual, ONCE ONLY. consider if blood loss >=350mL after 3rd stage oxytocin. Irrespective of route (vaginal, PR or sublingual), it takes 1-2.5hrs to increase uterine tone, it risks pyrexia & hypoT but it’s OK in asthma (BD)
What’s the 2nd most common cause of PPH?
Trauma (20%)- where fundus is well-contracted & blood is clotting. Surgeons need to expose & repair the tissues & clamp arterial bleeders- if t/f to OT, GA usually more appropriate if haemodynamically unstable.
What are some of the aetiologies of “trauma” in PPH & risk factors for these?
-Cervical trauma: profuse haemorrhage during & after 3rd stage. Risks= precipitous labour, assisted vaginal birth, cervical suture
-Uterine rupture: risk factors= previous uterine surgery or CS, oxytocin admin, malpresentation, cephalopelvic disproportion, foetal macrosomia, dystocia during 2nd stage labour, grand multip, placenta percreta, uterine abnormalities
-Uterine inversion: associated with immediate life-threatening haemorrhage & shock & pain disproportionate to the revealed blood loss. Risks= uterine over-distension, invasive placentation, excessive umbilical cord traction, tocolysis, primps.
What’s the 3rd most common cause of PPH & how is it managed?
Tissue (10%): retained products, placenta, membranes or clots. CCT & attempt delivery- to OT for manual removal & curettage if placenta adhered/trapped. Ergometrine is contraindicated, also avoid PGF2 alpha & oxytocin infusions.
What’s the 4th most common cause of PPH? what are the signs & how manage?
Thrombin (<1%): fundus contracted (but may become atonic secondary to FDPs) & blood not clotting. Oozing from puncture sites, petechial/subjonjunctival/mucosal haemorrhage, haematuria, temp <35deg
give rbc in response to haemodynamic changes & EBL rather than Hb trigger. Don’t give >2L crystalloid (less if PET).
-WARM fluids & pt (avoid hypothermia & acidosis)
-Consider early MHP activation IF active bleeding PLUS: anticipate 4 units rbc in <4hrs + haemodynamic instability, EBL >2.5L or any clinical or lab signs of coagulopathy. Activate with lab, inform whether or not using ROTEM or TEG & contact haematologist or ICU
Clear communication w the lab re: impending arrival of urgent blood samples & need for emerg blood & components
CONSIDER CELL SALVAGE
ideally cross-matched but use O neg tell neg blood in the meantime
monitor rotem or teg 10 mins after products given & do 30-minutely FBC, ABG, cogs, ionised Ca++
Goals:
-optimise oxygenation, cardiac output, Hb (all part of DO2), tissue perfusion, temp, metabolic state
-fibrinogen >2.5g/L
-platelets >50 x10^9/L
-PT or aPTT <1.5x normal
-INR <=1.5
-Ca++ >1.1mmol/L
-avoid hypothermia (keep temp >35) & acidosis (pH >7.2)
-BE -6 to +6
-Lactate <4mmol/L
-UO >=30mL/hr
-MAP titrated to maintain 65mmHg
Surgeons consider angiographic embolisation, balloon tamponade, billet uterine artery ligation or even hysterectomy
team lead deactivate MHP & return products after bleeding controlled
When is TxA given? what’s it’s role?
1g IV over 10 mins, ASAP after onset of haemorrhage (pref within 3hrs) for all PPH
If bleeding persists after 30 mins or stops then restarts within 24hrs, give a 2nd dose
WOMAN trial (Lancet 2017): 20,000 pts TxA vs placebo. TxA reduces death due to bleeding in women with PPH (RR 0.81), esp if given within 3hrs (RR 0.69) with no adverse effects. TxA + uterotonics reduce postpartum blood loss, blood transfusion, laparotomy to control bleeding & death due to PPH with no incr risk thromboembolic events or seizures (actually more seizures in placebo group of WOMAN trial)
What are some conditions associated with DIC?
placental abruption, AFE, severe PET or HELLP, acute fatty liver of pregnancy, IUFD, septicaemia, dilutional coagulopathy secondary to massive transfusion
What’s in our MHP pack 1 & 2?
4u rbc, 4U FFP. 10 units cryo. 4 units rbc, 4U FFP, 1 unit plt.
When & how replace Ca++?
10mL 10% calcium gluconate (3x less elemental Ca++ than CaCl but less risk tissue necrosis if extravasated) to maintain ionised Ca >1.1mmol/L
What’s the evidence for product ratio in PPH?
No evidence but QLD health suggest rbc:ffp 2:1 & 1 dose plt for every 2nd MHP pack (ie. every 8-10 units rbc if no plt level to guide)
What’s the main marker for severity of haemorrhage?
fibrinogen levels <=2g/L- associated w progression of bleeding, incr rbc & component requirement & the need for invasive procedures
What’s uterine blood flow @ term?
700mL/min
What’s normal pregnancy fibrinogen level?
5-6g/L (non pregnancy 2-4.5g/L)
Why is it important to give Kell -ve blood in all women of childbearing age where possible?
kell antigens are the 3rd most potent after ABO & Rh @ triggering an immune reaction. Can cause transfusion reactions & HDN.
Is the risk of VTE increased with PPH?
yes
What are some differentials for unknown cause of PPH?
suspicion for uterine rupture or inversion, concealed haematoma (eg. vault haematoma), puerperal haematoma (genital haematoma- due to vascular injury lower genital tract- hallmark= excessive or persistent pain, tachycardia), non-genital cause (sub capsular liver rupture, AFE), repeat 4Ts Ax
What ABx glven if manual removal placenta in OT?
ampicillin or 1st gen cephalosporin
What’s the equation for DO2?
CO x [{Hb x SaO2 x 1.34) + (PaO2 x 0.03)]
How long after blood products should you check a rotem?
10 mins
What are major risk factors for PPH?
Precipitous labour- OR 34
Uterine rupture- OR 23
Prev PPH >1.5L- OR 6
APH, retained placenta, anaemia or anticoagulants- OR 4
multiple pregnancy or IVF- OR 3
prolonged 3rd stage or PET: OR 3.5, prolonged 2nd stage OR 2
Instrumental VD: OR 1.8, CS with labour OR 1.7 and without labour OR 1.3
Other factors: AMA >=35, multiparty, ethnicity asian/africa/Pacific Islander, uterine fibroids, BMI >=30, GDM, polyhydramnios, IOL, macrosomia, perineal trauma, GA, infection, malpresentation
What type of blood should be given if antenatal blood transfusion required?
CMV neg
What are some risk minimisation principles for PPH?
identification of at risk, flagging on chart for when admitted
monitor Hb & optimise red cell mass prior to delivery- consider Mx of Fe deficiency (PO 1st line or Fe infusion) or blood transfusion if indicated
identify & treat chorioamnioitis (increases risk of PPH).
3rd stage oxytocic, institutional system for early identification & rapid management of PPH.
When might carbetocin be given?
If high risk PPH & spinal or epidural anaesthesia- after birth of baby, 100microg IV over 1 minute
Does early vs late cord clamping influence PPH risk? how about early feeding?
No & no
What are the benefits of carbetocin?
Stable at room temperatures. Following VD or CS (NOT studied under GA) it doesn’t reduce PPH risk cf oxytocin but does reduce the need for further uterotonics. May consider it after VD or CS under spinal or epidural if high risk PPH.
What are the benefits of TEG or ROTEM-guided transfusion strategies, as shown in low-quality evidence?
decrease time for blood test result avail
guide and evaluate haemostat Rx
distinguish btwn surgical causes bleeding & coagulopathy
Dx specific type of coagulation impairment
reduce blood product need
reduce morbidity in pts w bleeding
What are some safety concerns with carboprost?
PGF2alpha bronchoconstriction so contraindicated in asthma, also AVOID IV as may cause severe pulm HTN, also causes severe vasoconstriction (systemic HTN). Must have O2 therapy & monitoring of HR, SpO2 & BP prior to administering
What is the effectiveness of angiographic embolisation for intractable PPH?
90%, pt must be stable for procedure duration (approx 1hr)
What are some tocolytic drugs to relax cervical ring for manual replacement of an inverted uterus? What other considerations?
GTN 400microg spray
Terbutaline 250microg subcut (if IV, in 50microg boluses, monitor pulse & stop if >140bpm. may cause arrhythmias, hypoK)
Salbutamol 50microg IV at a time
magnesium sulphate 4g IV infusion over 5 mins
Must STOP any oxytocics (oxytocin infusion)
What are criteria for activating MHP in PPH?
Active bleeding and either: EBL >2.5L, estimated 4units in <4hrs + haemodynamic instability, any clinical or laboratory signs of coagulopathy
Why is fibrinogen important in PPH?
falls earlier than the other coagulation factors, may be low despite normal PT/APTT, fibrin/fibrinogen deficiency= the main informative marker for the severity of haemorrhage w levels <2g/L ass’d w progression of bleeding, incr rbc & component requirement & the need for invasive procedures
What are issues with recombinant VIIa?
Only indicated if specific factor deficiency. 90mcg/kg & costs approx 5k, has thrombotic complications, still requires plt & fibrinogen so transfuse plt & cryo before use
What should the base excess be for PPH?
greater than -6
What’s the max dose of ergometrine?
1mg IV or IM
What are some maternal & foetal signs of uterine rupture?
maternal abdo pain (constant), shoulder tip pain, uterine/suprapubic tenderness, tachycardia & signs of shock, sudden dyspnoea, change in uterine shape, abdomen palpation of foetal parts, frank haematuria or abnormal vaginal bleeding. foetus: abnormal ctg, loss of foetal station
How do we give & prepare salbutamol for tocolysis? side effects?
It’s a 5mg/5mL vial (1000microg/mL)- draw up 0.25mL & dilute it to 10mL (25microg/mL). give 50micorg (2mL) at a time, monitoring HR, stop if HR 140bpm.
Tachycardia (M&F), hypotension, SVT & ventricular ectopics, hyperglycaemia, may get hypoxia due to incr metabolic rate +/- fluid shift in lungs, pulmonary oedema, tremors if awake.
Why may we get hypocalcemia in massive transfusion?
citrate from transfused blood
Why give plasma-lyte?
It has no calcium so the citrate from the blood products won’t bind it. It doesn’t have lactate. It is physiologically close to our plasma (Na+ 140 vs 131 in Hartmann’s).
What do we transfuse while waiting for results of group & antibody testing?
O negative rbc (ideally kell -ve). once grouped & Ab-ve, transfuse with group-specific (ABO & Rh compatible blood). If antibodies, while awaiting compatible blood, consult haematologist & transfuse most suitable rbc.
Why give TxA over 10 mins?
Rapid infusion may cause hypotension & dizziness
What is the dose of fibrinogen per vial? By how much does 4g fib conc increase plasma fibrinogen?
1g. 4g increases plasma fibrinogen by 1g/L. Reconstitute with 50mL sterile water, SWIRL don’t shake. Shouldn’t give at >5mL/minute (ie. give over 10 mins)
What’s a standard adult dose of cryoprecipitate? How much fibrinogen does this contain?
10 units cryo (ie. 10x 20-30mL bags each of which contain approx 250g fibrinogen) if from whole blood, 5 units if from aphaeresis. Contains 3g fibrinogen.
What does cryoprecipitate contain?
factors VIII, XIII, vWF, fibrinogen, fibronectin
By how much does cryo increase fibrinogen?
1 unit (cryo from whole blood) per 10kg body wt increases fibrinogen by 1g/L (cryo from aphaeresis increases it by approx twice as much)
What happens to C3 & C4 levels in AFE?
reduced- low C3&C4 88-100% sens & 100% spec for AFE
What’s the principle of use of vasopressors during PPH?
just use to support vital organ perfusion
What’s the order of likelihood of rhythms w maternal cardiac arrest?
PEA, asystole, VF & VT
What’s blood volume @ end of pregnancy?
100mL/kg
What does the evidence show for use of NAdr vs phenylephrine for hypotension following spinal for LSCS?
significantly lower incidence of bradycardia, no significant increase in risk foetal acidosis, lower apgars, no significant differences in rates of nausea & in rates of hypotension btwn the 2 interventions
What’s ogilvie’s syndrome?
acute colonic pseudo-obstruction; massive dilatation of the colon in absence of mechanical obstruction
What’s the most common O&G procedure with which Ogilvie’s syndrome is associated?
caesarean
What’s the risk of not treating (decompressing) the colon in ogilvie’s syndrome?
perforation & acute faecal peritonitis with high associated M&M
Aside from pregnancy & caesarean, what are some other causes of ogilvie syndrome?
Pelvic surgery, trauma, intra-abdominal sepsis, myocardial or mesenteric ischemia, pneumonia, multiple sclerosis, drugs (eg. antidepressants)
Who is affected more by Olgivie syndrome.. males or females?
Males
What’s the usual treatment for ogilvie syndrome?
conservative- carries lower mortality (15 vs 40%)- NG decompression, colonoscopic decompression, correction of fluid & electrolyte balance, neostigmine, removal of implicated pharmacological factors (opioids, anticholinergics) or even epidural for sympathetic blockade
What are some first-line antihypertensives for pre-eclampsia?
methyldopa, labetalol
What does the consensus statement on uterotonic agents during caesarean section recommend as the dose for low-risk elective caesarean? How about if risk factors for PPH?
1IU bolus followed by infusion of 2.5-7.5IU/hr. If required, after 2 mins, can give a further bolus of 3 IU over >=30secs (for low-risk non-labouring pts, a small dose followed by infusion= optimal approach)
If higher risk for PPH or if intrapartum, the dose= 3IU over >=30 seconds followed by infusion 7.5-15IU/hr.
For both, the alternative is carbetocin, max 100microg (no higher due to risk tachycardia & arrhythmias) given over >=30 seconds.
How does carbetocin differ to oxytocin?
It’s a synthetic oxytocin analogue with similar mechanism of action & adverse effects profile, longer duration of action (plasma half-life 40 mins IV, 4-10x longer than oxytocin) as it’s less susceptible to metabolism & it has higher lipophilicity- so don’t need an infusion. No evidence for use w GA LSCS. Can be kept out of the fridge.
less potent than syntocinon (other synthetic oxytocin)
What are some adverse effects of oxytocin?
ST depression, arrhythmias (prol QTc), hypotension (reduces SVR 30%), rebound tachycardia (net incr CO), incr PVR/PAP (esp in pulm HTN), flushing, antidiuretic effect & hyponatremia (it has structural analogy to ADH so may have impact on V2 receptors but there’s minimal ADH effect), dose-related nausea & vomiting
It antagonises the effects of sux (need higher dose), it’s inactivated if co-administree w blood transufsions (can’t use same line)
Why are the recommended doses for oxytocin for intrapartum LSCS higher than elective?
oxytocin receptors undergo rapid homologous desensitisation & the receptor of labouring women, having been exposed to endogenous oxytocin infusion, are requiring a higher dose for effectiveness.
What are some benefits of adding in an infusion after initial oxytocin bolus?
Less PPH, less transfusion requirement, lower EBL, lower requirement for additional uterotonics
What happens to cardiac output after oxytocin administered?
Increases (54%), due to incr HR & SV (although it causes peripheral vasodilation & hypoT)
What happens to the cardiovascular responses to oxytocin w subsequent doses?
Attenuated, potentially due to receptor desensitisation
What’s the plasma half-life of ergometrine?
30-120mins
What’s the most prominent adverse effect after misoprostol (PGE1 analogue)?
hyperpyrexia
Are the categories of risk for medications during pregnancy hierarchical?
no
What’s pregnancy category A?
Medicines which have been taken by a large number of pregnant women and
women of childbearing age without any proven increase in the frequency of
malformations or other direct or indirect harmful effects on the fetus having been
observed.
What’s pregnancy category B1?
Medicines which have been taken by only a limited number of pregnant women and
women of childbearing age, without an increase in the frequency of malformation or
other direct or indirect harmful effects on the human fetus having been observed.
Studies in animals have not shown evidence of an increased occurrence of fetal
damage.
What’s pregnancy category B2?
Medicines which have been taken by only a limited number of pregnant women and
women of childbearing age, without an increase in the frequency of malformation
or other direct or indirect harmful effects on the human fetus having been
observed.
Studies in animals are inadequate or may be lacking, but available data show no
evidence of an increased occurrence of fetal damage.
What’s pregnancy category B3?
Medicines which have been taken by only a limited number of pregnant women and
women of childbearing age, without an increase in the frequency of malformation or
other direct or indirect harmful effects on the human fetus having been observed.
Studies in animals have shown evidence of an increased occurrence of fetal damage,
the significance of which is considered uncertain in humans.
What’s pregnancy category C?
Medicines which, owing to their pharmacological effects, have caused or may be
suspected of causing, harmful effects on the human fetus or neonate without
causing malformations. These effects may be reversible. Accompanying texts should
be consulted for further details.
What’s pregnancy category D?
Medicines which have caused, are suspected to have caused or may be expected to
cause, an increased incidence of human fetal malformations or irreversible damage.
These medicines may also have adverse pharmacological effects. Accompanying
texts should be consulted for further details.
What’s pregnancy category X?
Medicines which have such a high risk of causing permanent damage to the fetus
that they should not be used in pregnancy or when there is a possibility of
pregnancy.
What pregnancy category are NSAIDs?
C, except celecoxib which is B3
While NSAIDs are relatively safe in early to mid pregnancy, from what gestation should NSAIDs be discontinued? why?
32 wks, due to late pregnancy risks of renal or cardiac anomalies, pulm HTN, necrotising enterocolitis, interference w foetal brain development (& risking ICH), inhibit platelet production, may cause delayed labour & birth (inhibiting prostaglandin synthesis) & interference with amniotic fluid production (causing oligohydramnios). ALSO RISK PREMATURE CLOSURE DUCTUS ARTERIOSUS, OR 15
What does the literature tell us about the association between in-utero exposure to opioids & congenital malformations?
There is an association but it’s not possible to say if this is due to the opioid or the condition for which it was taken
What factors increase the risk of neonatal abstinence syndrome?
Dose & timing- higher dose & administration closer to delivery= higher risk NAS
Is intrauterine exposure to tramadol associated with congenital defects?
Yes, eg. cardiac & equinovarus
Is intra-uterine exposure to gabapentin or pregabalin associated with adverse effects?
There’s insufficient data on exposures to say; gabapentin can be associated with a withdrawal syndrome
What pregnancy class is parecoxib?
C
What are some concerns with aspirin in the last trimester? does 100mg/day PO affect bleeding time?
since it inhibits PG synthesis, may cause premature closure ductus arteriosus, delay in labour & birth, so products containing aspirin should be avoided in the last trimester
What are some concerns with aspirin in the last trimester? does 100mg/day PO affect bleeding time?
since it inhibits PG synthesis, may cause premature closure ductus arteriosus, delay in labour & birth, so products containing aspirin should be avoided in the last trimester
What are some concerns with aspirin in the last trimester? does 100mg/day PO affect bleeding time?
since it inhibits PG synthesis, may cause premature closure ductus arteriosus, delay in labour & birth, so products containing aspirin should be avoided in the last trimester
What are some concerns with aspirin in the last trimester? does 100mg/day PO affect bleeding time?
since it inhibits PG synthesis, may cause premature closure ductus arteriosus, delay in labour & birth, so products containing aspirin should be avoided in the last trimester
What pregnancy category are lignocaine, bupivacaine & cinchocaine?
A
What pregnancy category is ropivacaine?
B2
What category are SSRIs & TCAs (except the selective SSRI paroxetine which is D, the atypical mirtazapine is B3 & the SNRIs venlafaxine & desvenlafaxine which are B2)? biggest concern w them?
C, foetal withdrawal
What pregnancy category are Sodium valproate, phenytoin, carbamazepine & lamotrigine?
D
What pregnancy category is gabapentin?
B1
What pregnancy categories are metoclopramide & ondansetron, respectively?
A & B1
What pregnancy category are paracetamol, codeine, dihydrocodeine, lignocaine, bupivacaine & cinchocaine?
A
What is peripartum cardiomyopathy?
An idiopathic cardiomyopathy presenting with heart failure secondary to LV systolic dysfunction, developing in late pregnancy or in the early postpartum months. Most pts have NYHA class III-IV symptoms & LVEF <35% at diagnosis.
What’s the NT-pro BNP cutoff for acute HF? and BNP?
> 300, >100
What’s the largest indirect cause of maternal mortality?
Cardiovascular disease
What’s the first & second most common arrhythmia in pregnancy?
AF & supraventricular tachycardia
During what stage is HF most common?
postpartum
What investigations should be ordered if suspect peripartum cardiomyopathy?
ecg, CXR, BNP, echo
What are some differentials if a pt presents with symptoms such as orthopnoea, dyspnoea, arrhythmias, dizziness, pedal oedema, chest pain, fatigue, depression, cough & their BNP is elevated but LVEF on echo is >=45%? how about those symptoms but echo normal and BNP normal?
pulmonary embolism, AFE, isolated RV dysfunction, hypertensive disorders of pregnancy, eclampsia, sepsis
If BNP normal, consider pneumonia, anaemia, hypertensive disorders of preg, eclampsia, depression, renal disease, physiological changes
What has the highest mortality rate in pregnancy? What is the 6 month mortality of this condition?
peripartum cardiomyopathy, @ 2.4%, but it may be underdiagnosed
6% 6-month mortality
What’s the incidence of thromboembolism during pregnancy? What condition accounts for half of these?
7-23%
Mechanical valve thrombosis accounts for half
What may cause neurological injury?
Stretch, compression, transection, intraneural injection, neurotoxin or interruption to the blood supply